Table 1 Patient cohort characteristics of all enrolled patients including two that did not meet inclusion criteria for the final analysis
Variable | Patient without HCC (n = 104) | Patients with HCC (n = 61) | |
|---|---|---|---|
Continuous | Median (min, max) | Median (min, max) | p value (test method) |
Age (years) | 57 (28–74) | 64 (34–89) | < 0.001 (Wilcox) |
Number of HCC nodules | – | 1 (1–5) | – |
Size of largest HCC nodule (mm) | – | 27 (7–118) | – |
Categorical | Count (%) | Count (%) | |
|---|---|---|---|
Male sex | 44 (42.3) | 43 (70.5) | < 0.001 (Fisher) |
Child-class | 0.32 (Fisher) | ||
A | 60 (57.7) | 41 (67.2) | |
B | 43 (41.3) | 20 (32.8) | |
C (excluded) | 1 (1.0) | – | |
Etiology of cirrhosis | 0.17 (Chi-square) | ||
ALD | 26 (25.0) | 15 (24.6) | |
HBV | 2 (1.9) | 4 (6.6) | |
HCV | 20 (19.2) | 18 (29.5) | |
NASH | 33 (31.7) | 17 (27.9) | |
Other | 23 (22.1) | 7 (11.5) | |
BCLC stage | |||
Stage 0 | – | 10 (16.4) | – |
Stage A | – | 39 (63.9) | – |
Stage B | – | 11 (18.0) | – |
Stage D (excluded) | 1 (1.6) | – | |